May 14, 2018 / 11:55 AM / 2 months ago

Eli Lilly to buy cancer drug developer AurKa Pharma

May 14 (Reuters) - Drugmaker Eli Lilly and Co said on Monday it would buy AurKa Pharma Inc to get access to the privately-held company’s experimental cancer treatment for solid tumors.

AurKa Pharma shareholders will get an upfront payment of $110 million and will be eligible to receive up to $465 million in regulatory and sales milestones, Eli Lilly said in a statement.

Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below